Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
To learn more about Seeking Alpha Pro, click here.
-
Merck's Next-Gen Sleep Disorder Drug - A Blockbuster?Rx Stocks • Mon, Aug 27, 2012
-
Best Performing Russell 3,000 Stocks Year to DateBespoke Investment Group • Thu, Sep 2, 2010
-
Best and Worst Performing U.S. Stocks YTDBespoke Investment Group • Mon, Jul 26, 2010
-
Friday Options RecapFrederic Ruffy • Fri, Jul 2, 2010
-
Somaxon Pharmaceuticals, Inc. Q2 2008 Earnings Call TranscriptFri, Sep 5, 2008
-
Somaxon Pharmaceuticals Q4 2007 Earnings Call TranscriptThu, Apr 17, 2008
-
GlobeNewswire (Feb 5, 2013)
-
GlobeNewswire (Dec 17, 2012)
-
GlobeNewswire (Dec 11, 2012)
-
GlobeNewswire (Oct 31, 2012)
-
GlobeNewswire (Oct 22, 2012)
-
GlobeNewswire (Aug 27, 2012)
-
GlobeNewswire (Aug 7, 2012)
-
GlobeNewswire (Jul 30, 2012)
-
GlobeNewswire (Jul 24, 2012)
-
GlobeNewswire (Jul 20, 2012)
-
GlobeNewswire (Jul 19, 2012)
-
GlobeNewswire (Jul 17, 2012)
-
Business Wire (May 10, 2012)
-
Business Wire (Apr 30, 2012)
-
Business Wire (Apr 27, 2012)
-
Business Wire (Dec 19, 2011)
-
at MarketWatch.com (Nov 19, 2010)
-
at MarketWatch.com (Nov 19, 2010)
-
at MarketWatch.com (Aug 26, 2010)
SOMX vs. ETF Alternatives
Company Description
We are a specialty pharmaceutical company focused on the in-licensing, development and commercialization of proprietary branded products and late-stage product candidates for the treatment of diseases and disorders in the central nervous system therapeutic area. We submitted our NDA for Silenor®... More






